CO2024001078A2 - Método para preparar intermediario para síntesis de inhibidor de xantina oxidasa - Google Patents
Método para preparar intermediario para síntesis de inhibidor de xantina oxidasaInfo
- Publication number
- CO2024001078A2 CO2024001078A2 CONC2024/0001078A CO2024001078A CO2024001078A2 CO 2024001078 A2 CO2024001078 A2 CO 2024001078A2 CO 2024001078 A CO2024001078 A CO 2024001078A CO 2024001078 A2 CO2024001078 A2 CO 2024001078A2
- Authority
- CO
- Colombia
- Prior art keywords
- synthesis
- xanthine oxidase
- oxidase inhibitor
- preparing intermediate
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229940123769 Xanthine oxidase inhibitor Drugs 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 239000003064 xanthine oxidase inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona a un método para preparar un intermediario para síntesis de inhibidor de xantina oxidasa y, más específicamente, a un método para preparar compuestos de las fórmulas químicas 2 y 4 al utilizar materiales de partida y ligandos de bajo precio y al emplear las técnicas de extracción quelante y purificación.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210087042 | 2021-07-02 | ||
| PCT/KR2022/009544 WO2023277658A1 (ko) | 2021-07-02 | 2022-07-01 | 잔틴 옥시다아제 저해제 합성을 위한 중간체의 제조 방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024001078A2 true CO2024001078A2 (es) | 2024-03-07 |
Family
ID=84691985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0001078A CO2024001078A2 (es) | 2021-07-02 | 2024-01-31 | Método para preparar intermediario para síntesis de inhibidor de xantina oxidasa |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP4349809A1 (es) |
| KR (1) | KR20230006408A (es) |
| CN (1) | CN117561237A (es) |
| AR (1) | AR126353A1 (es) |
| AU (1) | AU2022302841A1 (es) |
| BR (1) | BR112023026062A2 (es) |
| CA (1) | CA3221122A1 (es) |
| CL (1) | CL2023003910A1 (es) |
| CO (1) | CO2024001078A2 (es) |
| TW (1) | TWI835186B (es) |
| WO (1) | WO2023277658A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW225535B (es) * | 1992-11-10 | 1994-06-21 | Hoechst Ag | |
| TWI423962B (zh) | 2009-10-07 | 2014-01-21 | Lg Life Sciences Ltd | 有效作為黃嘌呤氧化酶抑制劑之新穎化合物、其製備方法及含該化合物之醫藥組成物 |
| CN104341396A (zh) * | 2013-08-08 | 2015-02-11 | 上海医药集团股份有限公司 | 二芳基乙内酰脲衍生物、其制备方法、药物组合物和应用 |
| PT3152199T (pt) * | 2014-06-03 | 2018-11-26 | Idorsia Pharmaceuticals Ltd | Compostos de pirazol e a sua utilização como bloqueadores de canais de cálcio do tipo t |
-
2022
- 2022-07-01 KR KR1020220081195A patent/KR20230006408A/ko not_active Application Discontinuation
- 2022-07-01 CA CA3221122A patent/CA3221122A1/en active Pending
- 2022-07-01 AU AU2022302841A patent/AU2022302841A1/en active Pending
- 2022-07-01 AR ARP220101725A patent/AR126353A1/es unknown
- 2022-07-01 BR BR112023026062A patent/BR112023026062A2/pt unknown
- 2022-07-01 WO PCT/KR2022/009544 patent/WO2023277658A1/ko active Application Filing
- 2022-07-01 CN CN202280044250.8A patent/CN117561237A/zh active Pending
- 2022-07-01 EP EP22833711.9A patent/EP4349809A1/en active Pending
- 2022-07-01 TW TW111124828A patent/TWI835186B/zh active
-
2023
- 2023-12-27 CL CL2023003910A patent/CL2023003910A1/es unknown
-
2024
- 2024-01-31 CO CONC2024/0001078A patent/CO2024001078A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2023003910A1 (es) | 2024-05-31 |
| BR112023026062A2 (pt) | 2024-03-05 |
| TWI835186B (zh) | 2024-03-11 |
| TW202308994A (zh) | 2023-03-01 |
| WO2023277658A1 (ko) | 2023-01-05 |
| CA3221122A1 (en) | 2023-01-05 |
| EP4349809A1 (en) | 2024-04-10 |
| CN117561237A (zh) | 2024-02-13 |
| AR126353A1 (es) | 2023-10-11 |
| KR20230006408A (ko) | 2023-01-10 |
| AU2022302841A1 (en) | 2023-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200722086A (en) | Compounds comprising an oxazole or thiazole moiety, processes for making them and their uses | |
| MX2017008170A (es) | Metodo para sintetizar compuestos de carbonilo opticamente activos. | |
| EA201100620A1 (ru) | Способ получения 2-алкил-3-ароил-5-нитробензофуранов | |
| EA200870038A1 (ru) | Способ получения аминов | |
| CL2021000171A1 (es) | Procedimiento y productos intermedios para la preparación de bilastina | |
| AR047810A1 (es) | Proceso quimico | |
| CO2021009253A2 (es) | Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de síntesis | |
| EA202090933A1 (ru) | Способ получения гербицидных соединений пиридазинона | |
| CO2024001078A2 (es) | Método para preparar intermediario para síntesis de inhibidor de xantina oxidasa | |
| ATE354583T1 (de) | Verfahren zur herstellung c-7 substituierter 5- androstene | |
| DE602006005349D1 (de) | Verfahren zur herstellung von hydrazon-derivaten | |
| ATE482964T1 (de) | Herstellung von katalysatoren | |
| MX2021007511A (es) | Procedimiento para la preparacion de anilinas sustituidas. | |
| DE602004014264D1 (de) | Verfahren zur herstellung von olanzapin | |
| MX2021005343A (es) | Proceso para la preparacion de isoxazolinas opticamente enriquecidas. | |
| ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
| ATE553080T1 (de) | Verkürztes verfahren zur herstellung von l- lobelin | |
| MX2021006499A (es) | Proceso de preparacion de un enol eter biciclico. | |
| TW200621734A (en) | Process for preparing diarylcycloalkyl derivatives | |
| TR2023013421T2 (tr) | Method for preparing intermediate for synthesis of xanthine oxidase inhibitor | |
| ATE370950T1 (de) | Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol | |
| ATE486851T1 (de) | Verfahren zur herstellung von montekulast | |
| MX2022004066A (es) | Oxidacion de santaleno a santalol. | |
| DE502005003019D1 (de) | Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten | |
| ATE399167T1 (de) | Verfahren zur halbsynthese von deserpidin |